ATE116656T1 - Säurebeständige dideoxynucleoside, wirksam gegen den hiv-virus. - Google Patents

Säurebeständige dideoxynucleoside, wirksam gegen den hiv-virus.

Info

Publication number
ATE116656T1
ATE116656T1 AT88303248T AT88303248T ATE116656T1 AT E116656 T1 ATE116656 T1 AT E116656T1 AT 88303248 T AT88303248 T AT 88303248T AT 88303248 T AT88303248 T AT 88303248T AT E116656 T1 ATE116656 T1 AT E116656T1
Authority
AT
Austria
Prior art keywords
dideoxynucleosides
resistant
acid
effective against
hiv virus
Prior art date
Application number
AT88303248T
Other languages
English (en)
Inventor
Victor E Marquez
John S Driscoll
Christopher Kuo-Hou Tseng
Nih C
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Application granted granted Critical
Publication of ATE116656T1 publication Critical patent/ATE116656T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biotechnology (AREA)
  • AIDS & HIV (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT88303248T 1987-04-17 1988-04-12 Säurebeständige dideoxynucleoside, wirksam gegen den hiv-virus. ATE116656T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3940287A 1987-04-17 1987-04-17

Publications (1)

Publication Number Publication Date
ATE116656T1 true ATE116656T1 (de) 1995-01-15

Family

ID=21905250

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88303248T ATE116656T1 (de) 1987-04-17 1988-04-12 Säurebeständige dideoxynucleoside, wirksam gegen den hiv-virus.

Country Status (9)

Country Link
EP (1) EP0287313B1 (de)
JP (2) JPH0613547B2 (de)
AT (1) ATE116656T1 (de)
AU (1) AU603219B2 (de)
CA (1) CA1340645C (de)
DE (1) DE3852665T2 (de)
HK (1) HK1007431A1 (de)
IL (1) IL86040A (de)
WO (1) WO1988007861A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084445A (en) * 1986-05-01 1992-01-28 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine
US5077279A (en) * 1986-05-01 1991-12-31 University Of Georgia Research Foundation, Inc. 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition
EP0314011A3 (de) * 1987-10-30 1990-04-11 F. Hoffmann-La Roche Ag Purinderivate
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides
US5644043A (en) * 1988-02-16 1997-07-01 Eli Lilly And Company 2',3'-dideoxy-2',2'-difluoronucleosides and intermediates
JP3090456B2 (ja) * 1988-03-16 2000-09-18 スクリップス クリニック アンド リサーチ ファウンデーション 治療剤として有用な置換アデニン誘導体
JPH0232093A (ja) * 1988-06-08 1990-02-01 Merrell Dow Pharmaceut Inc 抗レトロウィルスジフルオロ化ヌクレオシド類
GB8816345D0 (en) * 1988-07-08 1988-08-10 Hoffmann La Roche Purine derivatives
FI95269C (fi) * 1989-05-15 1996-01-10 Squibb Bristol Myers Co 2',3'-dideoksi-inosiinimonohydraatin, 2',3'-dideoksi-2',3'-didehydrot ymidiinimonohydraatin ja 2',3'-dideoksi-2'-fluori-inosiinihemihydraatin antiviraalisia, hyvin vesiliukoisia, stabiileja, kiteisiä suoloja
US6207650B1 (en) 1989-05-15 2001-03-27 Bristol-Myers Squibb Company Antiviral, highly water soluble, stable, crystalline salts of 2′, 3′-dideoxyinosine, 2′, 3′-dideoxy-2′, 3′-didehydrothymidine and 2′, 3′-dideoxy-2′-fluoroinosine
GB8920534D0 (en) * 1989-09-11 1989-10-25 Wellcome Found Antiviral compounds
HU906976D0 (en) * 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
US5859221A (en) * 1990-01-11 1999-01-12 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5872232A (en) * 1990-01-11 1999-02-16 Isis Pharmaceuticals Inc. 2'-O-modified oligonucleotides
US6399754B1 (en) 1991-12-24 2002-06-04 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides
US5670633A (en) * 1990-01-11 1997-09-23 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides that detect and modulate gene expression
US6005087A (en) 1995-06-06 1999-12-21 Isis Pharmaceuticals, Inc. 2'-modified oligonucleotides
US5914396A (en) * 1990-01-11 1999-06-22 Isis Pharmaceuticals, Inc. 2'-O-modified nucleosides and phosphoramidites
US5378825A (en) * 1990-07-27 1995-01-03 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogs
US5623070A (en) * 1990-07-27 1997-04-22 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5618704A (en) * 1990-07-27 1997-04-08 Isis Pharmacueticals, Inc. Backbone-modified oligonucleotide analogs and preparation thereof through radical coupling
US5610289A (en) * 1990-07-27 1997-03-11 Isis Pharmaceuticals, Inc. Backbone modified oligonucleotide analogues
US5677437A (en) * 1990-07-27 1997-10-14 Isis Pharmaceuticals, Inc. Heteroatomic oligonucleoside linkages
US5792844A (en) * 1990-07-27 1998-08-11 Isis Pharmaceuticals, Inc. Oligonucleoside linkages containing adjacent nitrogen atoms
US5420115A (en) * 1990-09-10 1995-05-30 Burroughs Wellcome Co. Method for the treatment of protoza infections with 21 -deoxy-21 -fluoropurine nucleosides
US5965722A (en) * 1991-05-21 1999-10-12 Isis Pharmaceuticals, Inc. Antisense inhibition of ras gene with chimeric and alternating oligonucleotides
US7119184B2 (en) 1991-08-12 2006-10-10 Isis Pharmaceuticals, Inc. Oligonucleotides having A-DNA form and B-DNA form conformational geometry
US6307040B1 (en) 1992-03-05 2001-10-23 Isis Pharmaceuticals, Inc. Sugar modified oligonucleotides that detect and modulate gene expression
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US9096636B2 (en) 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US8604183B2 (en) 2002-11-05 2013-12-10 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2928773A (en) * 1958-11-17 1960-03-15 It Prodotti Schering Soc Process for preparing inosine
US4357824A (en) * 1980-09-15 1982-11-09 General Electric Company Method for determining volatilization rates of dissolved volatiles from solid waste materials
US4652554A (en) * 1982-02-22 1987-03-24 St. Jude Children's Research Hospital Nitro-substituted 1-β-D-arabinofuranosylcytosines
US4594339A (en) * 1982-04-06 1986-06-10 Sloan-Kettering Institute For Cancer Research Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-β-d-arabinofuranosyl)pyrimedene nucleosides
US4489052A (en) * 1982-09-15 1984-12-18 Sloan-Kettering For Cancer Research Quantitative autoradiographic mapping of focal herpes simplex virus encephalitis using a radiolabeled antiviral drug
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
AU575918B2 (en) * 1984-03-06 1988-08-11 Sloan-Kettering Institute For Cancer Research Hepatitis treatment with pyrimidine nucleoside compounds
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives

Also Published As

Publication number Publication date
EP0287313A3 (en) 1989-06-14
JPH01501628A (ja) 1989-06-08
WO1988007861A1 (en) 1988-10-20
IL86040A0 (en) 1988-09-30
EP0287313B1 (de) 1995-01-04
IL86040A (en) 1993-03-15
CA1340645C (en) 1999-07-13
JPH069680A (ja) 1994-01-18
AU1684488A (en) 1988-11-04
HK1007431A1 (en) 1999-04-09
EP0287313A2 (de) 1988-10-19
DE3852665T2 (de) 1995-05-11
AU603219B2 (en) 1990-11-08
DE3852665D1 (de) 1995-02-16
JPH0613547B2 (ja) 1994-02-23

Similar Documents

Publication Publication Date Title
DE3852665D1 (de) Säurebeständige Dideoxynucleoside, wirksam gegen den HIV-Virus.
EA200100757A1 (ru) Хинолинкарбоксамиды в качестве противовирусных агентов
NO892381D0 (no) 1-indolylalkyl-4-(substituert-pyridinyl)piperaziner.
ES2094150T3 (es) Derivado de triazina y herbicida que lo contiene a titulo de ingrediente activo.
DE69010139D1 (de) Haarkräftigungsmittel.
ES2045109T3 (es) 1-fenil-3-naftaleniloxipropanaminas.
NO860852L (no) Tilling derav.
ATE408598T1 (de) Bicyclische verbindung
GR3002618T3 (en) Solutions of oxazaphosphorins with enhanced stability and process for their preparation
FR2436779A1 (fr) Derives de pyrrolidine-2 methanol utilisables comme medicaments
SE8503415D0 (sv) Novel isoindolinyl-alkyl-piperazines
DE3879258D1 (de) Praeparat gegen ulcus.
MX9101059A (es) Composicion contra incrustaciones acuaticas
SE7709913L (sv) Sett att framstella penta peptider
CO5021214A1 (es) Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene
FI861934A0 (fi) Nya isoxazolderivat, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska preparat.
GB2021586A (en) 1,2,4-Triazolidin-3-ones (and -thiones)
ES2053530T3 (es) Compuestos macrolidos.
FI874585A0 (fi) Difenyleterherbicider.
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
RU94007089A (ru) Армированная полиолефиновая термопластическая композиция
DE69222438D1 (de) Aids-virus-infektion hemmende zusammensetzung
SE8505534L (sv) Kemiska foreningar
EA199700188A1 (ru) Пестициды
FR2366280A1 (fr) Nouvelles 1h-benzo(de)isoquinoleine-1,3(2h)-diones substituees en position 2, utiles comme agents anti-inflammatoires

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time